On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q3 2023 earnings per share (EPS) of -$0.14, up 12.5% year over year. Total Glycomimetics earnings for the quarter were -$9.20 million. In the same quarter last year, Glycomimetics's earnings per share (EPS) was -$0.16.
As of Q4 2023, Glycomimetics's earnings has grown year over year. Glycomimetics's earnings in the past year totalled -$38.07 million.
What was GLYC's revenue last quarter?
On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Glycomimetics's revenue was $0.00.
What was GLYC's revenue growth in the past year?
As of Q4 2023, Glycomimetics's revenue has grown -100% year over year. This is 210.58 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Glycomimetics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.